Jump to content
Pharmacy CJC-1295 An after-hours editorial digest of the CJC-1295 literature — what the GHRH-analog studies actually measured, why it is paired with ipamorelin, and where the DAC-vs-no-DAC story really stands.

study questions and corrections

Contact this CJC-1295 research guide

Send a paper question, report an error in a source, or name a study that may be missing.

The form is for paper questions and corrections

CJC-1295 is an unapproved study drug that prompts growth-hormone release. This page explains which questions the form can handle.

Send a question about a paper summary or the source behind a claim. You can also report a broken paper link or a study that may be missing.

The form cannot provide care, write a prescription, or arrange a sale. No health agency has cleared CJC-1295 for people [9].

Take personal health questions to your usual doctor or nurse. The site can't help with personal use.

Editors check each correction against the paper

Send a correction when a figure does not match its source. You can also report a wrong paper name or newer work that changes a claim.

Editors compare the note with the original paper before changing a page. That step protects you from claims based only on a secondhand summary.

Please flag any passage that mixes DAC with the short form or overstates a human finding. Those are the two errors the site most wants to avoid.